XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balance at Dec. 31, 2019 $ 698,426 $ (1,066) $ 12 $ 1,012,218 $ 29 $ (313,833) $ (1,066)
Balance, Shares at Dec. 31, 2019     119,897        
Vesting of early exercised stock options 32     32      
Issuance of common stock pursuant to equity incentive plans 11,206   $ 1 11,205      
Issuance of common stock pursuant to equity incentive plans, Shares     2,987        
Issuance of common stock in connection with at-the-market offering, net of issuance costs 497,242     497,242      
Issuance of common stock pursuant in connection with at-the-market offerings, net of issuance costs, Shares     4,000        
Stock-based compensation expense $ 95,348     95,348      
Accounting Standards Update Extensible List Accounting Standards Update201613 [Member]            
Net income (loss) $ (84,813)         (84,813)  
Balance at Sep. 30, 2020 1,216,375   $ 13 1,616,045 29 (399,712)  
Balance, Shares at Sep. 30, 2020     126,884        
Balance at Jun. 30, 2020 1,015,553   $ 12 1,428,171 29 (412,659)  
Balance, Shares at Jun. 30, 2020     124,584        
Vesting of early exercised stock options 6     6      
Issuance of common stock pursuant to equity incentive plans 5,329   $ 1 5,328      
Issuance of common stock pursuant to equity incentive plans, Shares     1,304        
Issuance of common stock in connection with at-the-market offering, net of issuance costs 147,633     147,633      
Issuance of common stock pursuant in connection with at-the-market offerings, net of issuance costs, Shares     996        
Stock-based compensation expense 34,907     34,907      
Net income (loss) 12,947         12,947  
Balance at Sep. 30, 2020 1,216,375   $ 13 1,616,045 29 (399,712)  
Balance, Shares at Sep. 30, 2020     126,884        
Balance at Dec. 31, 2020 1,328,015   $ 13 1,660,379 29 (332,406)  
Balance, Shares at Dec. 31, 2020     128,004        
Vesting of early exercised stock options 4     4      
Issuance of common stock pursuant to equity incentive plans 13,433     13,433      
Issuance of common stock pursuant to equity incentive plans, Shares     3,515        
Issuance of common stock in connection with at-the-market offering, net of issuance costs 989,615     989,615      
Issuance of common stock pursuant in connection with at-the-market offerings, net of issuance costs, Shares     2,637        
Stock-based compensation expense 133,866     133,866      
Net income (loss) 218,698         218,698  
Balance at Sep. 30, 2021 2,683,631   $ 13 2,797,297 29 (113,708)  
Balance, Shares at Sep. 30, 2021     134,156        
Balance at Jun. 30, 2021 2,561,028   $ 13 2,743,629 29 (182,643)  
Balance, Shares at Jun. 30, 2021     133,299        
Issuance of common stock pursuant to equity incentive plans 3,148     3,148      
Issuance of common stock pursuant to equity incentive plans, Shares     857        
Stock-based compensation expense 50,520     50,520      
Net income (loss) 68,935         68,935  
Balance at Sep. 30, 2021 $ 2,683,631   $ 13 $ 2,797,297 $ 29 $ (113,708)  
Balance, Shares at Sep. 30, 2021     134,156